Robert Gresham PhD Gilead Sciences

Robert Gresham started at Gilead Sciences in 2023 after the completion of his PhD in Biomedical Engineering at UC Davis. While at Davis, he worked on biomaterial synthesis and tissue engineering for use in musculoskeletal tissue regeneration approaches. At Gilead, he has leveraged this background to understand the response of tissue to long-acting injectable drug products. His work at Gilead has involved the development of in vitro, ex vivo, and in vivo models to inform rank ordering of drug product formulation or device selections. Recently, he has been engaged in identifying novel technologies to facilitate the delivery of Gilead's current and future portfolio of parenteral products.